Sunovion Pharmaceuticals Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sunovion Pharmaceuticals's estimated annual revenue is currently $292.3M per year.(i)
  • Sunovion Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Sunovion Pharmaceuticals has 1454 Employees.(i)
  • Sunovion Pharmaceuticals grew their employee count by -33% last year.

Sunovion Pharmaceuticals's People

NameTitleEmail/Phone
1
VP, Commercial Strategic OperationsReveal Email/Phone
2
Head Information TechnologyReveal Email/Phone
3
EVPReveal Email/Phone
4
SVP Chief Quality and Technical Operations OfficerReveal Email/Phone
5
Head, Global Data Science (Biometrics and Data Management)Reveal Email/Phone
6
VP - Head MarketingReveal Email/Phone
7
VP and ControllerReveal Email/Phone
8
VP Finance Strategy, Portfolio Management & OperationsReveal Email/Phone
9
VP Corporate OperationsReveal Email/Phone
10
VP, Market Access, FieldReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is Sunovion Pharmaceuticals?

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded an extensive portfolio of pharmaceutical compound candidates, including candidates for the treatment of respiratory, urology and central nervous system disorders. Sepracor's corporate headquarters are located in Marlborough, Massachusetts.

keywords:N/A

N/A

Total Funding

1454

Number of Employees

$292.3M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sunovion Pharmaceuticals News

2022-04-17 - Calming and Sleeping Market Size 2022 Analysis By Top ...

Eli Lilly; Astrazeneca; Johnson & Johnson; Sunovion Pharmaceuticals; Roscoe Medical; Acura Pharmaceuticals; Teva Pharmaceutical; Cara...

2022-04-17 - iLearn Schools Celebrates 15th Years of High-Quality Education

... Sunovion Pharmaceuticals, President and CEO of New Jersey Public Charter School Association Harry Lee and Executive Director of New York...

2022-04-13 - Pet Allergy Treatment Drugs Market 2022 Development Status ...

Sunovion Pharmaceuticals Inc, Allergon AB, AbbVie(Allergan), HAL Allergy Group, Allergy Therapeutics, Teva Pharmaceutical, Viatris,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$765.4M3823-6%$23.4M
#2
$5630M7477-11%$450M
#3
$11470M536044%$6.3B